Jill A Stewart, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Garfield St, Quinter, KS 67752 Phone: 785-754-3333 Fax: 785-754-2335 |
Michael E Machen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Garfield St, Quinter, KS 67752 Phone: 785-754-3333 Fax: 785-754-2335 |
Douglas J Gruenbacher, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Garfield St, Quinter, KS 67752 Phone: 785-754-3333 Fax: 785-754-2335 |
Shelly L Gruenbacher, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Garfield St, Quinter, KS 67752 Phone: 785-754-3333 Fax: 785-754-2335 |
News Archive
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Researchers at the Nanyang Technological University (NTU) Singapore, have developed new computational techniques and algorithms that can allow medical doctors to visualise and assess micro-vessel blood flow in tumours.
Doctors and researchers know that man-made chemicals commonly found in plastics, foods, personal care products and building materials can interfere with how hormones like estrogen and testosterone work in the body.
The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first break through in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.
Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.
› Verified 3 days ago